tirzepatide compared to semaglutide as with for the Treatment of Obesity Tirzepatide vs Semaglutide Compared |
Description
Hu W, Song R, Cheng R et al (2022) Use of GLP-1 receptor agonists and occurrence of thyroid disorders: a meta-analysis of randomized controlled trials
Wegovy is specifically designed to reduce appetite and promote weight loss, whilst bupropion is generally considered weight-neutral or may cause modest weight loss
Holmes says
24 10991104 (Wiley Online Library, 2004)
However, it also indicates favorable outcomes in studies for those who are obese or overweight but do not have diabetes
